E Fund Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Sell
14,858
-10,854
-42% -$117K 0.01% 439
2026
Q1
$218K Buy
+25,712
New +$281K 0.01% 437
2025
Q2
$190K Buy
13,492
+2,307
+21% +$41.1K 0.01% 364
2025
Q1
$269K Buy
11,185
+1,572
+16% +$55.4K 0.01% 329
2024
Q4
$359K Buy
9,613
+775
+9% +$36.2K 0.02% 280
2024
Q3
$442K Sell
8,838
-3,045
-26% -$118K 0.02% 210
2024
Q2
$412K Buy
11,883
+4,407
+59% +$174K 0.02% 196
2024
Q1
$409K Sell
7,476
-7,052
-49% -$349K 0.03% 213
2023
Q4
$622K Sell
14,528
-3,080
-17% -$95.8K 0.04% 122
2023
Q3
$458K Buy
17,608
+7,415
+73% +$154K 0.03% 136
2023
Q2
$244K Sell
10,193
-10,040
-50% -$173K 0.02% 251
2023
Q1
$276K Buy
20,233
+1,759
+10% +$28K 0.02% 243
2022
Q4
$256K Buy
18,474
+15,241
+471% +$215K 0.02% 255
2022
Q3
$478K Buy
+3,233
New +$23.5K 0.04% 132

Other funds holding BHVN

E Fund Management's BHVN Position: Q2 2026 in Review

E Fund Management reduced its Biohaven (BHVN) stake by 42% in Q2 2026, selling an estimated $117K and leaving 14,858 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #439.

E Fund Management first reported a position in BHVN in Q3 2022 and has held it in 14 quarters since. The position peaked at $622K in Q4 2023. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • E Fund Management held 14,858 shares of Biohaven worth $221K as of Q2 2026.
  • E Fund Management sold 10,854 Biohaven shares in Q2 2026, an estimated $117K.
  • Biohaven made up 0.01% of E Fund Management's portfolio in Q2 2026, its #439 holding.
  • E Fund Management first reported a position in Biohaven in Q3 2022 and has held it in 14 quarters since.
  • E Fund Management's Biohaven position peaked at $622K in Q4 2023.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.